相关实验视频

Updated: Jul 1, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

循环RNAs作为新的治疗实体和工具用于在急性髓性白血病的目标识别

Adam Nopora¹, Ulrich H Weidle¹

¹Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany adam.nopora@roche.com weidle49@t-online.de.

Cancer genomics & proteomics

|February 29, 2024

概括

循环RNAs (circRNAs) 在急性髓性白血病 (AML) 中显示出作为治疗点的潜力. 研究人员确定了许多circRNA,为药物开发提供了新的途径,以对抗AML耐药性.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一种遗传学.

背景情况:

急性髓性白血病 (AML) 是一种复杂的癌症,具有显著的耐药性问题.
确定新的治疗点对于改善AML患者的存活率至关重要.
循环RNAs (circRNAs) 正在成为癌症的关键参与者,作为瘤基因或瘤抑制剂.

研究的目的:

确定和评估循环RNAs (circRNAs) 作为急性髓性白血病 (AML) 的潜在治疗点.
在临床前AML模型中探索上调和下调循环RNA的治疗潜力.

主要方法:

在PubMed的系统文献搜索中,寻找AML中circRNAs的研究.
在临床前的体外和体内模型中分析具有报告活性的circRNAs.
基于其表达水平 (上调或下调) 的circRNAs的分类.

主要成果:

在临床前的体内AML模型中,有8个上调和2个下调的circRNAs表现出活性.
22个上调和4个下调的circRNAs在临床前的体外AML系统中表现出活性.
鉴定的circRNAs提供了不同的治疗策略:准高调RNA或补充低调RNA.

结论:

循环RNAs代表了新型AML治疗的有希望的目标.
可利用RNA干扰或小分子对上调节的circRNA进行向.
下调circRNAs可以通过替代策略进行治疗调节,等待进一步验证.

关键词:

驱动器突变的变异遗传异质性的遗传异质性在临床前验证.复制疗法是一种复制疗法.审查审查审查审查审查审查这是一个shRNARNA.siRNA 是一个RNA.

更多相关视频

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...